GLOFITAMAB+R‐CHOP IN PATIENTS WITH PREVIOUSLY UNTREATED LARGE B‐CELL LYMPHOMA DEFINED AS HIGH RISK BY CIRCULATING TUMOR DNA (ctDNA) DYNAMICS: PRIMARY RESULTS | Publicación